Preprints are evidence-based article manuscripts that have not yet undergone peer review. They are the newest existing research.
Early-stage research, not yet peer-reviewed.
Article manuscripts regarding outbreaks, and that are undergoing peer review.
Multiple members of CMMID are working on the ongoing Covid-19 (previously referred to as novel coronavirus or nCov) outbreak caused by the SARS-CoV-2 virus. This page shows an overview of our work. We regularly update this page with new and updated work. Works have not yet been peer-reviewed.
COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
This resource is the National Library of Medicine (NLM) database of links to disaster medicine and public health documents available on the Internet at no cost. Documents include expert guidelines, research reports, conference proceedings, training classes, fact sheets, websites, databases, and similar materials for a professional audience. NLM selects materials from over 1,400 non-commercial publishing sources and supplements disaster-related resources from PubMed (biomedical journal literature) and MedlinePlus (health information for the public).
Free access to BioOne Journal articles related to the coronavirus.
Collection of articles from BMJ on coronavirus.
Free access to coronavirus information from The Lancet.
Information from the Journal of the American Medical Association.
Elsevier’s free health and medical research on novel coronavirus (COVID-19)
Free access to articles in Springer and Nature journals related to coronavirus.
Free access to articles and books chapters regarding coronavirus from the publisher Wiley.
Daily case reports and time series.
This template looks at the potential economy- and sector-specific economic impact of the COVID-19 outbreak
Datasets found in publications within the Dimensions database.
A series of data files with cumulative counts of coronavirus cases in the U.S., at the state and county level, over time.
The collective expertise, capabilities, data and insights of healthcare organizations, technology firms, nonprofits, academia, and startups.
A full-text search engine for free data provided by the White House and leading research groups. It includes over 47,000 scholarly articles about COVID-19, SARS-CoV-2, and related coronaviruses.
Data in these papers are free for unrestricted use, distribution and reproduction in any medium, provided that the original work is properly cited as indicated by (CC BY IGO 3.0).
Collects and publishes the most complete testing data available for US states and territories.
Tracks and compares government responses to the coronavirus outbreak worldwide.
Information on all things relative to COVID-19, including risk factors and national spending on healthcare services.
Genomic data from GenBank.
Genomic data from GenBank and the Sequence Read Archive.